The global desalting and buffer exchange market is projected to reach USD 1,094.8 million by 2023 from USD 679.8 million in 2018, at a CAGR of 10.0%. The base year considered for the study is 2017, and the market forecast is provided for 2018–2023. Growth in this market will largely be driven by increasing demand for mAbs, increasing R&D expenditure by pharmaceutical and biopharmaceutical companies, and growing focus on proteomic and genomic research.
The market is segmented into major 3 techniques: filtration, chromatography, and precipitation. In 2018, the filtration segment is expected to account for the largest share of the global market. The large share of this segment is attributed to the increased production of biologics and growth in proteomics and genomics research.
In 2018, in terms of value, North America is expected to account for the largest share of the global market. The large share of this regional segment is attributed to the increasing demand for biopharmaceuticals, rising R&D expenditure by biopharmaceutical companies, and growing research activities in the field of genomics and proteomics.
Download TOC : https://www.marketsandmarkets.com/Market-Reports/desalting-buffer-exchange-market-3721738.html
Key players in the global change market are Thermo Fisher Scientific (US), Merck (US), GE Healthcare (US), Danaher (US), and Sartorius (Germany). These players focus on inorganic and organic strategies such as expansions, acquisitions and agreements to sustain their growth in the market.
Desalting and Buffer Exchange Market: Target Audience:
- Filtration and chromatography manufacturers, vendors, and distributors
- Research and consulting firms
- Pharmaceutical and biotechnology manufacturers
- Contract research organizations (CROs)
- Contract manufacturing organizations (CMOs)
- Market research and consulting firms
Comments
Post a Comment